Biotechnology
Manufacturing
Health
Biogen
$231.279876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$231.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.96 (-0.41%) Today
$0.00 (0.00%) As of 5:05 PM EDT after-hours
Why Robinhood?
You can buy or sell Biogen and other stocks, options, ETFs, and crypto commission-free!
About BIIB
Biogen Inc. Common Stock, also called Biogen, is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Read More It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Employees
7,800
Headquarters
Cambridge, Massachusetts
Founded
1978
Market Cap
50.65B
Price-Earnings Ratio
9.96
Dividend Yield
0.00
Average Volume
1.23M
High Today
$234.10
Low Today
$231.09
Open Price
$232.86
Volume
1.32M
52 Week High
$388.67
52 Week Low
$216.12
Collections
Biotechnology
Manufacturing
Health
Therapy
Technology
US
North America
BIIB News
Price Paid on Robinhood
5% Lower
Right Now
52 Week Low
$216.12
Average Price Paid
$244.60
52 Week High
$388.67
Analyst Ratings
23%
of 30 ratings
Buy
23%
Hold
70%
Sell
7%
BIIB Earnings
$5.26
$6.00
$6.73
$7.47
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$7.47 per share
Actual
Available Jul 23, Pre-Market